POSTER SESSION I Monday, March 24, 2003   —  9:30 AM - 12:00 Noon Exhibit Hall A - C DERMATOPATHOLOGY 68 The Use of a Novel Tyrosinase Assay for the Detection of Melanoma Cells in Cytologic Preparations (388) C Angeletti, V Khomitch, R Halaban, DL Rimm Yale School of Medicine, New Haven, CT 69 Nodal Melanocytic Nevi in Sentinel Lymph Nodes Correlate with the Presence of Melanoma Associated Cutaneous Nevi (409) JB Holt, OP Sangueza, EA Levine, P Shen, S Bergman, KR Geisinger, AJ Creager Duke University Medical Center, Durham, NC; Wake Forest University Baptist Medical Center, Winston-Salem, NC 70 Aberrant Methylation of Tumor Suppressor Genes in Sporadic Cutaneous Cancer (424) P Makarla, AY Moore, A Padar, AF Gazdar Hamon Center for Therapeutic Oncology Research, Dallas, TX; University of Texas Southwestern Medical Center, Dallas, TX 71 Desmoplastic Melanoma: Rare Involvement of Sentinel Lymph Nodes Despite Deep Invasion (426) JA McCay, MC Kelley, CR Schmidt, JF Simpson Vanderbilt University Medical Center, Nashville, TN 72 Proliferation, Survivin Expression and Angiogenesis in Malignant Melanoma: Relationship to Conventional Prognostic Parameters (434) DC Parker, G Cotsonis, D Sexton, C Cohen Emory University School of Medicine, Atlanta, GA 73 Cyclin D1 Expression in Melanocytic Lesions of the Skin (439) JA Ramirez, K Wang, MS Rao, L Diaz Feinberg School of Medicine Northwestern University, Chicago, IL